Flagship Wealth Advisors LLC Purchases New Position in Aflac Incorporated (NYSE:AFL)

Flagship Wealth Advisors LLC purchased a new stake in shares of Aflac Incorporated (NYSE:AFL) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 1,200 shares of the financial services provider’s stock, valued at approximately $124,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Whipplewood Advisors LLC bought a new stake in Aflac during the 4th quarter worth approximately $26,000. Darwin Wealth Management LLC bought a new stake in Aflac during the 3rd quarter worth approximately $34,000. BankPlus Trust Department bought a new stake in Aflac during the 4th quarter worth approximately $34,000. Curio Wealth LLC bought a new stake in Aflac during the 4th quarter worth approximately $36,000. Finally, Raelipskie Partnership bought a new stake in Aflac during the 3rd quarter worth approximately $38,000. 67.44% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

AFL has been the topic of a number of analyst reports. Morgan Stanley upped their price objective on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. BMO Capital Markets initiated coverage on shares of Aflac in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price objective on the stock. Barclays reduced their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Keefe, Bruyette & Woods reduced their price objective on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 12th. Finally, Wells Fargo & Company reduced their price objective on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 19th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $103.36.

Aflac Stock Up 1.1 %

Aflac stock opened at $108.47 on Tuesday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50. The firm’s fifty day moving average is $105.51 and its 200 day moving average is $107.67. The company has a market capitalization of $59.29 billion, a PE ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, sell-side analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insiders Place Their Bets

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of the company’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the transaction, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 55,546 shares of company stock worth $5,863,616. Insiders own 0.90% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.